New non-hormonal therapy for endometriosis wins MedChem Australia funding to fast-track drug discovery Monash University
New non-hormonal therapy for endometriosis wins MedChem Australia funding to fast-track drug discovery monash.edu
Pregnant women with coronavirus disease 2019 (COVID-19) are more likely than nonpregnant women to require admission to an intensive care unit, and many may require antiviral therapy. Remdesivir, an antiviral …
Endometriosis is a complex chronic inflammatory disease with an unclear etiology and limited treatment options, severely affecting the reproductive health and quality of life of many women. Histone deacetylases (HDACs), …
Endometriosis is a chronic, heterogeneous gynaecological disorder characterised by the presence of endometrial-like tissue outside the uterine cavity and is associated with pain, infertility, and reduced quality of life. Emerging …
Endometriosis is a chronic estrogen-dependent inflammatory disorder affecting approximately 10% of women of reproductive age. It remains a major contributor to chronic pelvic pain, infertility, and reduced quality of life. …
Endometriosis Menstrual Pain Dropped to Minimal or No Pain After a Median of 8 Weeks With Relugolix Therapy Gilmore Health
Endometriosis Menstrual Pain Dropped to Minimal or No Pain After a Median of 8 Weeks With Relugolix Therapy gilmorehealth.com
Relugolix is an oral, non-peptide gonadotropin-releasing hormone receptor antagonist administered as once-daily combination therapy (relugolix-CT; 40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetate) to reduce endometriosis symptoms while …
FocalTherics' Ryan Rhodes: Focal One HIFU Is Building a Prostate Therapy Category, Not Just a Device finance.biggo.com